Want to see EPC full AI Analyst Report?
Top Page
Edgewell Personal Care
(NYSE:EPC)
Select Model
Select Model
Rating:56Neutral
Price Target:
$29.00
▲(23.93% Upside)
Action:Reiterated
Date:06/27/26
The score is held back primarily by weakened financial performance, including a TTM net loss and lower cash generation versus prior years, despite a manageable balance sheet. Technicals are supportive with strong price trend and positive momentum, but overbought indicators increase near-term risk. Valuation is mixed (negative P/E due to losses, partially offset by a ~2.16% dividend), while the earnings call adds moderate support via reaffirmed guidance and H2 recovery initiatives tempered by ongoing margin and cost headwinds.
Positive Factors
Market share and volume momentum
Consistent share gains and extended U.S. volume share momentum indicate durable brand competitiveness and retail execution. Sustained share growth across geographies supports stable shelf placement, promotional leverage and recurring demand, making revenue recovery more structural than transitory.
Negative Factors
TTM profitability deterioration
The swing to a TTM net loss and negative margins is a structural red flag for return generation. Negative ROE and reduced profitability limit reinvestment capacity, reduce buffer for cost shocks and pressure management’s ability to rebuild earnings without sustained top-line or margin improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Market share and volume momentum
Consistent share gains and extended U.S. volume share momentum indicate durable brand competitiveness and retail execution. Sustained share growth across geographies supports stable shelf placement, promotional leverage and recurring demand, making revenue recovery more structural than transitory.
Read all positive factors
Edgewell Personal Care Key Performance Indicators (KPIs)
Any
Operating Income by Segment
Reports operating profit for each segment, revealing which businesses generate sustainable profits after costs, which dilute margins, and where management should prioritize cost control or capital allocation to improve overall profitability.
Reports operating profit for each segment, revealing which businesses generate sustainable profits after costs, which dilute margins, and where management should prioritize cost control or capital allocation to improve overall profitability.
Data provided by:
The Fly
The FlyEdgewell Personal Care (EPC) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.28B
Dividend Yield3.51%
Average Volume (3M)800.44K
Price to Earnings (P/E)―
Beta (1Y)0.38
Revenue Growth-5.30%
EPS Growth-196.78%
CountryUS
Employees6,700
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-1.69
Shares Outstanding46,081,326
10 Day Avg. Volume775,628
30 Day Avg. Volume800,439
Financial Highlights & Ratios
PEG Ratio-0.52
Price to Book (P/B)0.62
Price to Sales (P/S)0.43
P/FCF Ratio23.36
Enterprise Value/Market Cap1.58
Enterprise Value/Revenue0.96
Enterprise Value/Gross Profit2.34
Enterprise Value/Ebitda18.00
Forecast
1Y Price Target
$25.20Price Target Upside7.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)1.9
Revenue Forecast (FY)$2.00B
Edgewell Personal Care Business Overview & Revenue Model
Company Description
Edgewell Personal Care Company, along with its associated businesses, is a global producer and distributor of a diverse range of personal care items. The company organizes its operations into three main divisions: Wet Shave, Sun and Skin Care, and...
How the Company Makes Money
Edgewell makes money by selling branded personal care products to retailers and distributors (and, in some cases, directly to consumers via e-commerce). Its revenue is generated mainly from product sales across its core categories: (1) Wet shave: ...
Edgewell Personal Care Earnings Call Summary
Earnings Call Date:May 06, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Aug 11, 2026
Earnings Call Sentiment Neutral
The call presented a mixed but stable picture: the company highlighted meaningful commercial progress (market share gains across many markets, strong grooming growth, international resilience), material productivity savings, and strategic portfolio simplification (Fem Care divestiture) that support a return to growth in H2. At the same time, results showed near-term revenue and margin pressure (organic sales down, adjusted gross margin down ~310 bps), lower profitability and cash use, currency and inflation/tariff headwinds, and one-time execution costs tied to supply-chain consolidation. Management reaffirmed guidance and emphasized H2 recovery levers, but tangible financial declines in the quarter balance the constructive operational momentum.Positive Updates
Market Share and Consumption Momentum
Improved consumption and market share trends: U.S. value share rose ~50 basis points in the quarter; branded share increased ~40 basis points (led by Billie +40 bps). Management reports growing or holding market share in ~80% of markets (up from ~70% in Q1) and 26 weeks of consecutive U.S. volume share growth.
Negative Updates
Organic Sales Decline and Regional Weakness
Organic net sales declined ~240 basis points (−2.4%) in the quarter. North America organic net sales decreased ~4.8%; North America Wet Shave declined ~6%. Sun & Skin organic net sales decreased ~4.5%, driven by Sun Care phasing and order timing.
Read all updates
Q2-2026 Updates
Positive
Negative
Market Share and Consumption Momentum
Improved consumption and market share trends: U.S. value share rose ~50 basis points in the quarter; branded share increased ~40 basis points (led by Billie +40 bps). Management reports growing or holding market share in ~80% of markets (up from ~70% in Q1) and 26 weeks of consecutive U.S. volume share growth.
Read all positive updates
Company Guidance
Edgewell reaffirmed its fiscal 2026 outlook with organic net sales expected to be down 1% to up 2% (ex‑FX), anticipating International mid‑single‑digit growth in H2 and North America low single‑digit growth in H2; Q3 net sales are forecast up 2%–3% with Q3 adjusted gross margin of 44%–45% (sequential improvement) and reported gross‑margin accretion for the year of ~+50 bps (down 10 bps for FX). Management noted ~220 bps of gross productivity savings this quarter versus ~420 bps of core inflation/tariff headwinds (plus 70 bps mix/promo and 40 bps currency), expects Q3 A&P to be the peak (15%–16% of sales) and a full‑year A&P rate up ~70 bps, and reiterated adjusted EPS of $1.70–$2.10 (assumed tax rate 22%–23%), adjusted EBITDA $245M–$265M, adjusted free cash flow $80M–$110M, ~40%–45% of second‑half adjusted EBITDA and EPS to fall in Q3, and year‑end adjusted net‑debt leverage of 3.3x–3.5x (including a 0.3–0.4 temporary FemCare timing impact), while flagging a near‑term $3M–$5M margin effect from the Middle East.Edgewell Personal Care Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
58
Neutral
Cash Flow
55
Neutral
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.11B | 2.22B | 2.25B | 2.25B | 2.17B | 2.09B |
| Gross Profit | 863.70M | 924.90M | 955.70M | 940.80M | 880.50M | 951.20M |
| EBITDA | 112.20M | 185.60M | 285.40M | 317.60M | 285.40M | 302.10M |
| Net Income | -77.80M | 25.40M | 98.60M | 114.70M | 99.50M | 117.80M |
Balance Sheet | ||||||
| Total Assets | 3.53B | 3.76B | 3.73B | 3.74B | 3.71B | 3.67B |
| Cash, Cash Equivalents and Short-Term Investments | 299.70M | 225.70M | 209.10M | 216.40M | 188.70M | 479.20M |
| Total Debt | 1.28B | 1.54B | 1.39B | 1.45B | 1.46B | 1.32B |
| Total Liabilities | 2.09B | 2.20B | 2.15B | 2.20B | 2.25B | 2.09B |
| Stockholders Equity | 1.45B | 1.55B | 1.58B | 1.54B | 1.47B | 1.58B |
Cash Flow | ||||||
| Free Cash Flow | 48.60M | 41.40M | 174.50M | 166.60M | 45.60M | 172.20M |
| Operating Cash Flow | 117.30M | 118.40M | 231.00M | 216.10M | 102.00M | 229.00M |
| Investing Cash Flow | 275.20M | -72.90M | -62.40M | -50.50M | -355.40M | -48.70M |
| Financing Cash Flow | -269.90M | -30.00M | -179.40M | -146.50M | -17.60M | -65.40M |
Edgewell Personal Care Technical Analysis
Positive
23.40
Price Trends
20.91
Positive
20.90
Positive
19.68
Positive
Market Momentum
1.83
Negative
76.47
Negative
90.76
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EPC, the sentiment is Positive. The current price of 23.4 is above the 20-day moving average (MA) of 21.91, above the 50-day MA of 20.91, and above the 200-day MA of 19.68, indicating a bullish trend. The MACD of 1.83 indicates Negative momentum. The RSI at 76.47 is Negative, neither overbought nor oversold. The STOCH value of 90.76 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EPC.
Edgewell Personal Care Risk Analysis
Edgewell Personal Care disclosed 28 risk factors in its most recent earnings report. Edgewell Personal Care reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Edgewell Personal Care Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $2.03B | 16.54 | 6.65% | 3.15% | -3.76% | 148.09% | |
65 Neutral | $23.59B | 32.69 | 17.45% | 1.38% | 2.22% | 29.40% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $36.30B | 17.17 | 143.64% | 5.03% | -16.17% | -13.40% | |
56 Neutral | $1.28B | -16.40 | -5.14% | 3.51% | -5.30% | -196.78% | |
52 Neutral | $2.47B | -8.71 | -11.10% | 7.76% | -4.11% | -14.23% | |
52 Neutral | $1.69B | -3.10 | -15.12% | ― | -3.57% | -32.30% |
* Consumer Defensive Sector Average
EPC
Edgewell Personal Care
27.72
4.99
21.93%
CHD
Church & Dwight
99.58
4.71
4.97%
KMB
Kimberly Clark
109.37
-13.53
-11.01%
NWL
Newell Brands
5.82
0.77
15.22%
SPB
Spectrum Brands Holdings
87.49
35.68
68.87%
COTY
Coty
1.92
-2.73
-58.71%
Edgewell Personal Care Corporate Events
Business Operations and StrategyExecutive/Board Changes
Edgewell Names New Chief Supply Chain Officer
Neutral
May 26, 2026
On May 20, 2026, Edgewell Personal Care Company announced that Chief Supply Chain Officer Paul R. Hibbert will leave his role effective June 1, 2026, and that he will receive payments and benefits under the company’s executive severance plan...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.